EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

A Quest for Survival: A Review of the Early Biomarkers of Pancreatic Cancer and the Most Effective Approaches at Present

Muhammad Begawan Bestari iD, Ignatius Ronaldi Joewono iD, Ari Fahrial Syam iD

Biomolecules · 19.03.2024 · 14 (3) · 364

DOI: 10.3390/biom14030364 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 19.03.2024. Verfasst von Muhammad Begawan Bestari und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterohepatology, Department of Internal Medicine, Hasan Sadikin General Hospital, Faculty of Medicine, University of Padjadjaran, …. Hauptthemen laut MEDLINE: MicroRNAs, Pancreatic Neoplasms. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 143 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pancreatic cancer (PC) is the most lethal type of cancer; it has the lowest 5-year survival rate among all other types of cancers. More than half of PC cases are diagnosed at an advanced stage due to PC’s insidious and non-specific symptoms. Surgery remains the most efficacious treatment option currently available, but only 10–20% of PC cases are resectable upon diagnosis. As of now, the sole biomarker approved by the United States Food and Drug Administration (US-FDA) for PC is carbohydrate antigen 19-9 (CA19-9); however, its use is limited for early diagnosis. An increasing number of studies have investigated a combination of biomarkers. Lately, there has been considerable interest in the application of a liquid biopsy, including the utilization of microRNAs (miRNAs), circulating tumor DNA (ctDNA), and circulating tumor cells (CTCs). Screening for PC is indicated for high-risk patients; studies on new diagnostic models combined with biomarkers for early detection have also shown promising results in terms of the ability of these models and biomarkers to aid clinicians in deciding on whether to start screening. This review seeks to provide a concise overview of the advancements in relation to existing biomarkers and explore novel strategies for the early detection of PC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsPancreatic NeoplasmsHumansBiomarkers, TumorDNA, NeoplasmLiquid Biopsy

Stichwörter der Autor:innen

early biomarkerearly diagnosispancreatic cancer

Substanzen

Biomarkers, TumorMicroRNAsDNA, Neoplasm

Autor:innen und Institutionen

  • Division of Gastroenterohepatology, Department of Internal Medicine, Hasan Sadikin General Hospital, Faculty of Medicine, University of Padjadjaran, Bandung 40161, Indonesia.
  • Mochtar Riady Comprehensive Cancer Center, Siloam Hospitals, Jakarta 12930, Indonesia.
  • Division of Gastroenterology, Department of Internal Medicine, Cipto Mangunkusumo National Central Hospital, Faculty of Medicine, University of Indonesia, Jakarta 10430, Indonesia.

ORCID-Profile: Muhammad Begawan Bestari, Ignatius Ronaldi Joewono, Ari Fahrial Syam

Zitieren

APA

Bestari, M. B., Joewono, I. R., & Syam, A. F. (2024). A Quest for Survival: A Review of the Early Biomarkers of Pancreatic Cancer and the Most Effective Approaches at Present. Biomolecules, 14(3), 364. https://doi.org/10.3390/biom14030364

Vancouver

Bestari MB, Joewono IR, Syam AF. A Quest for Survival: A Review of the Early Biomarkers of Pancreatic Cancer and the Most Effective Approaches at Present. Biomolecules. 2024;14(3):364. doi:10.3390/biom14030364

BibTeX
@article{Bestari2024,
  author = {Bestari, Muhammad Begawan and Joewono, Ignatius Ronaldi and Syam, Ari Fahrial},
  title = {A Quest for Survival: A Review of the Early Biomarkers of Pancreatic Cancer and the Most Effective Approaches at Present},
  journal = {Biomolecules},
  year = {2024},
  volume = {14},
  number = {3},
  pages = {364},
  doi = {10.3390/biom14030364}
}
Kostenlos starten →